respiratori
syncyti
viru
rsv
major
infecti
caus
lower
respiratori
tract
ill
infant
young
children
around
also
recogn
import
etiolog
agent
pneumonia
respiratori
tract
infect
adult
elderli
clinic
present
infect
vari
wide
mild
upper
respiratori
tract
diseas
bronchiol
viru
respons
major
bronchiol
case
caus
approxim
pneumonia
case
first
year
children
host
factor
young
age
prematur
chronic
cardiopulmonari
diseas
associ
sever
diseas
addit
factor
lower
socioeconom
statu
exposur
cigarett
smoke
air
pollut
crowd
household
lack
breastfeed
also
associ
sever
viral
factor
associ
virul
lead
sever
diseas
suffici
human
rsv
member
paramyxovirida
famili
outbreak
rsv
infect
occur
fall
spring
temper
climat
tend
last
rsv
isol
divid
two
group
group
group
b
base
antigen
genet
two
group
cocircul
human
popul
group
preval
sever
studi
compar
sever
diseas
infant
infect
rsv
group
group
b
mix
result
studi
found
signific
clinic
differ
howev
possibl
effect
differ
viral
strain
diseas
sever
remain
open
question
despit
recogn
import
rsv
caus
respiratori
ill
inform
regard
epidemiolog
viru
latin
america
particularli
among
adult
present
studi
case
rsv
infect
identifi
four
epidem
year
mexico
evalu
clarifi
epidemiolog
infect
assess
possibl
variat
demograph
clinic
characterist
accord
viral
group
new
influenza
strain
influenza
viru
identifi
viru
spread
worldwid
caus
signific
morbid
mortal
recogn
multipl
pathogen
may
present
respiratori
symptom
includ
ill
ili
improv
understand
epidemiolog
featur
respiratori
tract
infect
caus
influenza
virus
mexico
cohort
studi
determin
etiolog
clinic
characterist
patient
present
ili
perform
studi
conduct
mexican
emerg
infecti
diseas
clinic
research
network
la
red
collabor
establish
mexican
ministri
health
us
nation
institut
allergi
infecti
diseas
studi
studi
carri
five
hospit
mexico
citi
one
san
lui
result
patient
enrol
first
year
studi
previous
report
analyz
characterist
patient
children
adult
confirm
rsv
infect
includ
studi
period
patient
month
old
present
ili
particip
hospit
elig
particip
studi
ili
defin
presenc
least
one
respiratori
symptom
eg
short
breath
nasal
congest
cough
one
two
follow
criteria
fever
examin
fever
feverish
past
hour
ii
one
symptom
eg
malais
headach
myalgia
chest
pain
order
rule
nosocomi
infect
patient
hospit
hour
time
symptom
onset
exclud
studi
subject
interview
examin
time
enrol
nasopharyng
swab
obtain
detect
respiratori
pathogen
blood
sampl
complet
blood
count
chemistri
analysi
obtain
avail
result
test
obtain
standard
clinic
care
extract
medic
record
subject
evalu
day
enrol
inform
also
obtain
telephon
call
day
enrol
visit
clinic
inform
symptom
rehospit
death
assess
visit
allow
ascertain
final
disposit
studi
patient
outpati
emerg
room
hospit
ward
intens
care
unit
icu
nasopharyng
swab
specimen
collect
enrol
patient
place
tube
viral
transport
media
maintain
refriger
sent
molecular
biolog
laboratori
infecti
diseas
depart
instituto
nacion
de
ciencia
salvador
store
sampl
patient
enrol
san
lui
maintain
refriger
transport
medic
school
universidad
de
san
lui
store
sent
instituto
nacion
de
ciencia
salvador
storag
virolog
test
sampl
sent
san
lui
mexico
citi
ship
dri
ice
nasopharyng
swab
test
polymeras
chain
reaction
influenza
follow
center
diseas
control
prevent
protocol
describ
respiratori
sampl
also
test
respifind
april
may
respifind
previous
respifind
plu
june
march
pathofind
bv
maastricht
netherland
multiplex
test
detect
differenti
virus
coronaviru
human
metapneumoviru
influenza
influenza
influenza
b
parainfluenza
viru
type
rsv
b
rhinoviru
adenoviru
well
four
bacteria
bordetella
pertussi
chlamydophila
pneumonia
legionella
pneumophila
mycoplasma
pneumonia
respifind
remov
influenza
ad
bocaviru
type
coronaviru
influenza
enteroviru
verbal
consent
obtain
parentsleg
tutor
subject
screen
determin
elig
patient
determin
elig
studi
particip
written
inform
consent
assent
children
older
year
obtain
protocol
approv
institut
review
board
hospit
mean
standard
deviat
use
summar
quantit
variabl
frequenc
percentag
use
qualit
variabl
comparison
group
made
use
student
quantit
variabl
fisher
exact
test
qualit
variabl
multivari
logist
regress
analysi
use
determin
factor
associ
hospit
icu
admiss
data
analyz
use
pspp
openepi
p
valu
consid
statist
signific
subject
enrol
studi
patient
respiratori
sampl
avail
viral
test
therefor
final
sampl
size
analysi
subject
subject
case
rsv
infect
rsv
infect
rsv
b
six
rsv
b
detect
fig
rsv
case
detect
throughout
studi
period
howev
mark
season
observ
high
number
case
fall
winter
decreas
detect
spring
summer
fig
rsv
predomin
viru
season
rsv
subtyp
circul
simultan
characterist
patient
rsv
infect
compar
patient
enrol
studi
tabl
age
group
affect
frequent
rsv
children
year
age
rsv
infect
occur
children
age
group
occur
adult
children
year
age
respiratori
tract
infect
children
year
caus
rsv
compar
children
older
year
adult
also
proport
case
seen
outpati
lower
patient
rsv
infect
compar
viru
detect
proport
icu
admiss
higher
tabl
patient
anoth
pathogen
detect
addit
rsv
patient
one
addit
pathogen
detect
case
two
one
case
three
includ
rhinoviru
coronavirus
parainfluenza
virus
influenza
influenza
b
adenoviru
metapneumoviru
bordetella
pertussi
mycoplasma
bocaviru
proport
infect
caus
rsv
subtyp
presenc
coinfect
accord
age
group
shown
fig
compar
characterist
infect
caus
rsv
rsv
b
assess
whether
signific
clinic
differ
tabl
six
case
coinfect
rsv
b
exclud
analysi
find
differ
medic
histori
patient
rsv
rsv
b
infect
also
compar
frequenc
symptom
patient
rsv
rsv
b
infect
signific
differ
observ
symptom
record
includ
fever
cough
sore
throat
fatigu
headach
myalgia
eye
symptom
sneez
rhinorrhea
short
breath
nausea
vomit
diarrhea
confus
malais
irrit
data
shown
addit
compar
clinic
characterist
patient
without
coinfect
pathogen
tabl
differ
age
group
distribut
note
case
without
coinfect
pathogen
proport
pediatr
case
higher
infect
caus
rsv
larger
proport
coinfect
note
adult
symptom
frequent
patient
infect
caus
rsv
compar
coinfect
data
shown
howev
differ
frequenc
symptom
patient
coinfect
report
fatigu
vs
headach
vs
frequent
without
coinfect
hand
presenc
rale
vs
wheez
vs
short
breath
vs
note
less
frequent
among
patient
coinfect
compar
rsv
pathogen
proport
hospit
patient
higher
infect
rsv
compar
respiratori
pathogen
vs
p
howev
increas
proport
icu
admiss
note
vs
assess
role
coinfect
factor
sever
rsv
infect
compar
characterist
patient
admit
hospit
treat
outpati
differ
risk
factor
describ
pediatr
adult
patient
separ
analysi
carri
two
group
tabl
variabl
signific
associ
univari
analysi
p
includ
multivari
logist
regress
model
children
factor
signific
independ
associ
rsv
hospit
includ
patient
age
younger
children
higher
risk
presenc
anoth
respiratori
pathogen
reduc
risk
coinfect
tabl
adult
signific
associ
patient
age
older
patient
higher
risk
odd
ratio
ci
p
sex
higher
risk
male
ci
p
presenc
underli
condit
ci
asthma
ci
risk
hospit
tabl
final
assess
factor
associ
admiss
icu
hospit
patient
three
patient
requir
icu
admiss
adult
therefor
analysi
associ
factor
limit
group
children
tabl
children
rsv
infect
admit
less
frequent
icu
rsv
b
infect
howev
multivari
analysi
differ
statist
signific
detect
respiratori
pathogen
addit
rsv
ci
well
presenc
cardiovascular
disord
ci
p
chronic
lung
diseas
ci
p
show
signific
associ
need
admiss
icu
analysi
limit
children
present
characterist
rsv
infect
detect
prospect
multicent
studi
children
adult
seek
clinic
care
data
obtain
four
season
provid
descript
epidemiolog
rsv
infect
mexico
among
peopl
age
present
hospit
ili
infect
caus
viru
detect
notabl
season
distribut
high
circul
fall
winter
overal
highest
number
detect
record
octob
decemb
predomin
subtyp
rsv
four
season
although
last
season
includ
studi
number
rsv
b
detect
similar
rsv
recent
year
grow
interest
impact
rsv
infect
adult
rsv
report
one
lead
caus
pneumonia
adult
behind
streptococcu
pneumonia
influenza
studi
rsv
detect
adult
respiratori
tract
infect
ili
previou
studi
also
found
signific
role
rsv
adult
instanc
johnston
et
presenc
rsv
case
pneumonia
adult
recent
studi
includ
adult
respiratori
tract
infect
assess
emerg
room
hospit
rsv
also
detect
anoth
studi
rsv
detect
respiratori
ill
subject
year
countri
ili
preval
hospit
thu
result
consist
previou
report
suggest
rsv
import
caus
ili
may
associ
hospit
studi
multipl
virus
detect
sampl
children
adult
use
multiplex
assay
detect
differ
respiratori
pathogen
combin
rsv
rhinoviru
coinfect
frequent
found
role
virus
rsv
infect
subject
previou
rhinoviru
one
frequent
report
virus
combin
increas
diseas
sever
viral
coinfect
suggest
sever
report
howev
studi
concur
studi
found
differ
regard
children
adult
appar
effect
viral
coinfect
observ
adult
children
rsv
infect
pathogen
detect
hospit
less
frequent
infect
rsv
howev
among
hospit
children
presenc
anoth
respiratori
pathogen
associ
admiss
icu
order
interpret
result
import
take
account
wide
varieti
coinfect
pathogen
case
two
even
three
virus
addit
rsv
detect
one
main
object
studi
identifi
factor
associ
sever
diseas
lead
rsv
hospit
countri
approxim
subject
rsv
infect
enrol
studi
least
one
underli
disord
frequent
condit
includ
congenit
malformationscongenit
syndrom
cardiovascular
disord
chronic
lung
diseas
asthma
observ
signific
differ
factor
associ
hospit
children
adult
multivari
logist
regress
analysi
indic
young
age
main
variabl
associ
hospit
children
adult
show
associ
addit
factor
requir
hospit
age
group
multivari
logist
regress
analysi
show
associ
rsv
infect
age
presenc
underli
condit
asthma
global
studi
respiratori
tract
viral
infect
elderli
adult
falsey
et
congest
heart
failur
cardiopulmonari
diseas
noninflammatori
cerebrovascularneurolog
disord
appear
associ
rsv
infect
howev
multivari
analysi
specif
factor
associ
viru
group
children
multivari
logist
regress
analysi
show
associ
risk
icu
admiss
presenc
coinfect
respiratori
pathogen
cardiovascular
disord
chronic
obstruct
lung
diseas
cohort
studi
children
sever
rsv
infect
conduct
england
multipl
preexist
diseas
rel
risk
congenit
cardiac
defect
rel
risk
consid
risk
factor
death
sever
rsv
recent
multicent
studi
perform
spain
et
compar
clinic
characterist
two
group
children
rsv
infect
vs
without
underli
diseas
found
patient
respiratori
tract
diseas
requir
oxygen
therapi
often
ci
addit
mechan
ventil
use
patient
cardiac
diseas
ci
inborn
error
metabol
ci
subgroup
show
higher
risk
admiss
icu
ci
present
studi
detect
signific
differ
sever
subgroup
subgroup
b
rsv
infect
report
indic
subgroup
rsv
associ
sever
diseas
wherea
other
found
regard
systemat
prospect
collect
detail
clinic
data
studi
well
inclus
patient
wide
spectrum
diseas
sever
support
conclus
clinic
signific
differ
diseas
present
seen
major
rsv
subtyp
whether
specif
strain
within
subgroup
associ
sever
ill
remain
unclear
instanc
martinello
et
show
clade
associ
greater
sever
ill
howev
strain
belong
clade
appear
minor
among
current
circul
rsv
studi
subject
limit
elig
studi
particip
subject
fulfil
ili
definit
establish
project
patient
respiratori
tract
infect
elig
inclus
nevertheless
definit
ili
allow
wide
spectrum
diseas
sever
includ
studi
limit
includ
fact
presenc
underli
condit
includ
histori
prematur
chronic
diseas
base
patient
might
total
reliabl
also
collect
data
palivizumab
use
might
relev
infant
howev
access
prophylaxi
limit
mexico
high
cost
therefor
number
patient
may
receiv
like
low
hand
strength
studi
includ
particip
sever
institut
inclus
patient
age
allow
us
report
characterist
rsv
infect
children
adult
mexico
studi
illustr
import
rsv
caus
seriou
respiratori
ill
affect
pediatr
patient
observ
similar
influenza
young
infant
elderli
show
higher
proport
hospit
adult
howev
precis
role
differ
underli
condit
risk
factor
sever
infect
popul
could
establish
addit
prospect
studi
need
identifi
popul
may
benefit
current
futur
prevent
intervent
rsv
vaccin
ana
e
hospit
infantil
de
federico
gomez
involv
concept
design
data
analysi
correl
result
write
manuscript
final
approv
version
publish
sarbelio
hospit
infantil
de
federico
gomez
involv
coordin
patient
enrol
data
collect
interpret
result
revis
intellectu
content
manuscript
final
approv
version
publish
beatriz
instituto
nacion
de
involv
coordin
patient
enrol
data
collect
interpret
result
revis
intellectu
content
manuscript
final
approv
version
publish
ana
instituto
nacion
de
involv
project
coordin
patient
enrol
data
collect
interpret
result
revis
intellectu
content
manuscript
final
approv
version
publish
lourd
instituto
nacion
de
ciencia
salvador
involv
data
collect
databas
revis
interpret
result
revis
intellectu
content
manuscript
final
approv
version
publish
arturo
instituto
nacion
de
ciencia
salvador
involv
project
coordin
patient
enrol
data
collect
interpret
data
result
revis
intellectu
content
manuscript
final
approv
version
publish
juan
f
involv
coordin
variou
hospit
network
coordin
data
sampl
collect
revis
intellectu
content
manuscript
final
approv
version
publish
francisco
j
involv
statist
analysi
interpret
data
revis
intellectu
content
manuscript
final
approv
version
publish
john
h
beigel
leido
biomed
involv
project
coordin
interpret
data
result
revis
intellectu
content
manuscript
final
approv
version
publish
guillermo
instituto
nacion
de
ciencia
salvador
involv
project
coordin
interpret
data
result
revis
intellectu
content
manuscript
final
approv
version
publish
daniel
e
noyola
universidad
de
san
lui
involv
concept
design
data
analysi
correl
result
write
manuscript
final
approv
version
publish
la
red
fund
mexico
ministri
health
us
nation
institut
allergi
infecti
diseas
project
fund
part
fund
provid
conacyt
fondo
sectori
ssaimssissst
project
nation
institut
allergi
infecti
diseas
nation
institut
health
intramur
research
program
contract
westat
inc
contract
number
task
order
number
nation
cancer
institut
nation
institut
health
contract
content
public
necessarili
reflect
view
polici
depart
health
human
servic
westat
mention
trade
name
commerci
product
organ
impli
endors
us
govern
e
noyola
particip
member
speaker
bureau
abbvi
rest
author
declar
relev
conflict
interest
report
